Pregnenolone 150mg Micronized Lipid Matrix 60t
Pregnenolone 150mg Micronized Lipid Matrix 60t by Allergy Research Group
Pregnenolone 150mg by Allergy Research Group provides a lipid matrix to bypass the liver so that the pregnenolone is presented directly to the systemic circulation, and it is micronized to a particle size of less than 50 microns for optimal absorption. Soy free – the source material (wild yam) is non-irradiated and non-ethylene-oxide-treated.
Allergy Research Group suggests taking 1 Pregnenolone 150mg tablet daily with a meal, or as directed by a healthcare practitioner.
Serving Size: 1 tablet
Servings Per Container: 60
Amount Per Serving:
Pregnenolone 150 mg
Other ingredients: Micosolle®, microcrystalline cellulose, vegetable oil, vegetable wax, Cab-o-sil®, magnesium stearate, vitamin E.
Variations in product color may occur. Keep Pregnenolone 150mg by Allergy Research Group in a cool, dry place, tightly capped.
WARNING: NOT FOR USE BY INDIVIDUALS UNDER THE AGE OF 18 YEARS. DO NOT USE IF PREGNANT OR NURSING. Consult a physician or licensed qualified health care professional before using this product if you have, or have a family history of, prostate cancer, prostate enlargement, heart disease, low "good" cholesterol (HDL), or if you are using any other dietary supplement, prescription drug, or over-the-counter drug. Do not exceed recommended serving. Exceeding recommended serving may cause serious adverse health effects. Possible side effects include acne, hair loss, hair growth on the face (in women), aggressiveness, irritability, and increased levels of estrogen. Discontinue use and call a physician or licensed qualified health care professional immediately if you experience rapid heartbeat, dizziness, blurred vision, or other similar symptoms. KEEP OUT OF REACH OF CHILDREN. Pregnenolone may affect levels of other hormones, such as progesterone, estrogen, testosterone, and/or DHEA. Do not take this product if you have a history of seizures. Do not take this product if you have breast cancer, prostate cancer, or other hormone-sensitive diseases.